by Adrian Manz | Apr 9, 2026 | The Doctor's Dose
Intel Stock Rally: Why the Move Has Traders Paying Attention Now Intel has gone from laggard to leader in a hurry, and that sudden shift is exactly why traders need to pay attention. After a massive six-day burst higher, the stock pushed to levels not seen in...
by Adrian Manz | Apr 8, 2026 | The Doctor's Dose
Why Defense Stocks Didn’t Surge After the Iran Cease-Fire When traders hear about military escalation followed by a sudden pause in hostilities, the instinct is often simple: buy defense. But the market rarely rewards simple thinking. The latest defense stocks...
by Adrian Manz | Apr 7, 2026 | The Doctor's Dose
Cease-Fire Rally: How to Trade Extended Futures at the Open Markets surged overnight after a surprise geopolitical development: a two-week cease-fire agreement between the U.S. and Iran, along with a reopening of the Strait of Hormuz. Stock futures jumped nearly 2%,...
by Adrian Manz | Apr 6, 2026 | The Doctor's Dose
Trump Iran Oil Market Impact: What Traders Should Really Be Watching Right Now The market is once again being forced to interpret geopolitical risk in real time. President Donald Trump’s escalating threats toward Iran—including the possibility of rapid strikes on...
by Julie Manz | Apr 2, 2026 | The Doctor's Dose
Why the opening hour exposes every weakness in a trader’s process—and how professionals handle it differently The first hour of the trading day offers some of the biggest opportunities in the market. It also creates some of the biggest mistakes. If you want to...
by Adrian Manz | Apr 2, 2026 | The Doctor's Dose
War Profits and Market Rotation: How Defense Spending Is Driving Stock Market Opportunity While most traders focus on headlines, professionals focus on where capital is flowing. And right now, one of the clearest flows in the market is coming from a source many...
by Adrian Manz | Apr 1, 2026 | The Doctor's Dose
Pharma Tariff Market Impact: What Trump’s Drug Pricing Push Could Mean for Traders A new policy headline is moving closer to the center of the market conversation, and it could matter far beyond healthcare. Reports indicate that the Trump administration is preparing...
by Adrian Manz | Apr 1, 2026 | The Doctor's Dose
How Trump’s Speech Could Impact the Stock Market Tonight Why Tonight’s Speech Matters Most presidential speeches do not move markets for very long. But tonight may be different. Markets are already trading on expectations tied to the war in Iran, oil prices, and the...
by Julie Manz | Mar 29, 2026 | The Doctor's Dose
The psychology behind one of the most common and expensive trading mistakes If you want to understand why traders overtrade, you have to look deeper than the trades themselves. Overtrading is not just a bad habit. It is usually a symptom of something else: lack of...
by Adrian Manz | Mar 26, 2026 | The Doctor's Dose
Why Traders Who Execute 50+ Trades in a Single Stock Almost Always Lose Money There’s a hard truth in trading that most people do not want to hear: The more you trade, the worse you often perform. And nowhere is that more obvious than with traders who execute 50 or...
